Regeneron operating performance, pipeline diversity seen in Q3, says Piper

Piper Jaffray analyst Christopher Raymond reiterates an Overweight rating and $450 price target on Regeneron’s shares following Q3 top- and bottom-line beats. The analyst notes that over the last five quarters including Q3, EPS has beaten consensus on average by 55c, consistently driven by top-line beats. Combining strong operational performance with continued pipeline maturation and commercial momentum, the analyst continues to like the setup and remains a buyer.
https://thefly.com/landingPageNews.php?id=2818651